EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical outcome of an SCNT-derived MSTN knockout buffalo: a case study

Priyanka Singh, Kartikey Patel, Gaurav Tripathi, Shavi Verma, Kusum Kashyap, Ranjeet Verma, Babu Lal Jangir, Manoj Kumar Singh, Naresh L Selokar

Frontiers in Genome Editing · 09.06.2026 · 8

DOI: 10.3389/fgeed.2026.1822169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Genome Editing, online erschienen am 09.06.2026. Verfasst von Priyanka Singh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Animal Biotechnology Division (ABTD), ICAR-National Dairy Research Institute (NDRI), Karnal, Haryana, India. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Agricultural Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myostatin ( MSTN ) gene knockout has attracted considerable interest for enhancing meat production in livestock species due to its well-established role as a negative regulator of skeletal muscle growth. In this study, we report the clinical outcome of a bi-allelic MSTN knockout buffalo produced via somatic cell nuclear transfer (SCNT) that failed to survive beyond 100 days of age. The MSTN knockout calf exhibited a double-muscling phenotype, which was validated by changes in mRNA expression of transcripts associated with increased muscle mass and reduced subcutaneous fat. In addition, the calf had a telomere length similar to that of age-matched calves produced through artificial insemination. However, serum biochemistry analysis revealed decreased levels of globulin, GGTP, ALP, and bilirubin, alongside increased concentrations of AST, urea, blood urea nitrogen, uric acid, phosphorus, and potassium. Cytokine profiling (including IFN-γ, IL-1α, IL-1β, IL-4, IL-6, IL-8, IL-10, IL-17α, IL-36Rα, TNF-α, MIP-1α, MIP-1β, MCP-1, IP-10, and VEGF-α) demonstrated dysregulation of several inflammatory and chemotactic mediators. This case report highlights potential health and welfare challenges associated with producing MSTN knockout buffalo through cloning-based approaches.

Schlagwörter

Stichwörter der Autor:innen

buffalogenome editingimmunometabolic regulationmuscle growthmyostatin knockoutsomatic cell nuclear transfer

Autor:innen und Institutionen

  • Animal Biotechnology Division (ABTD), ICAR-National Dairy Research Institute (NDRI), Karnal, Haryana, India.
  • Department of Veterinary Pathology, College of Veterinary Sciences, Lala Lajpat Rai University of Veterinary and Animal Sciences (LUVAS), Hisar, India.

Förderung

  • Indian Council of Agricultural Research

Zitieren

APA

Singh, P., Patel, K., Tripathi, G., Verma, S., Kashyap, K., Verma, R., Jangir, B. L., Singh, M. K., & Selokar, N. L. (2026). Clinical outcome of an SCNT-derived MSTN knockout buffalo: a case study. Frontiers in Genome Editing, 8. https://doi.org/10.3389/fgeed.2026.1822169

Vancouver

Singh P, Patel K, Tripathi G, Verma S, Kashyap K, Verma R, et al. Clinical outcome of an SCNT-derived MSTN knockout buffalo: a case study. Frontiers in Genome Editing. 2026;8. doi:10.3389/fgeed.2026.1822169

BibTeX
@article{Singh2026,
  author = {Singh, Priyanka and Patel, Kartikey and Tripathi, Gaurav and Verma, Shavi and Kashyap, Kusum and Verma, Ranjeet and Jangir, Babu Lal and Singh, Manoj Kumar and Selokar, Naresh L},
  title = {Clinical outcome of an SCNT-derived MSTN knockout buffalo: a case study},
  journal = {Frontiers in Genome Editing},
  year = {2026},
  volume = {8},
  doi = {10.3389/fgeed.2026.1822169}
}
Kostenlos starten →